Deutsche Bank
CTKB icon

Deutsche Bank’s Cytek Biosciences CTKB Stock Holding History

Deutsche Bank’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$456K Buy
104,437
+11,298
+12% +$53.3K ﹤0.01% 2617
2025
Q4 		$470K Buy
93,139
+4,119
+5% +$19.1K ﹤0.01% 2606
2025
Q3 		$309K Buy
89,020
+11,972
+16% +$44.9K ﹤0.01% 2830
2025
Q2 		$262K Sell
77,048
-16,906
-18% -$56.3K ﹤0.01% 2816
2025
Q1 		$377K Sell
93,954
-9,228
-9% -$47.8K ﹤0.01% 2632
2024
Q4 		$670K Buy
103,182
+36,542
+55% +$218K ﹤0.01% 2468
2024
Q3 		$369K Buy
66,640
+9,725
+17% +$55.1K ﹤0.01% 2625
2024
Q2 		$318K Sell
56,915
-10,241
-15% -$61.5K ﹤0.01% 2568
2024
Q1 		$451K Buy
67,156
+1,552
+2% +$12.3K ﹤0.01% 2408
2023
Q4 		$598K Sell
65,604
-1,258
-2% -$7.92K ﹤0.01% 2289
2023
Q3 		$369K Buy
66,862
+15,811
+31% +$127K ﹤0.01% 2366
2023
Q2 		$436K Sell
51,051
-24,043
-32% -$216K ﹤0.01% 2435
2023
Q1 		$690K Buy
75,094
+18,637
+33% +$200K ﹤0.01% 2309
2022
Q4 		$576K Buy
56,457
+4,790
+9% +$64.4K ﹤0.01% 2364
2022
Q3 		$761K Sell
51,667
-5,725
-10% -$74.4K ﹤0.01% 2141
2022
Q2 		$616K Buy
57,392
+2,808
+5% +$27.9K ﹤0.01% 2471
2022
Q1 		$588K Buy
54,584
+44,165
+424% +$596K ﹤0.01% 2650
2021
Q4 		$170K Buy
10,419
+543
+5% +$11.4K ﹤0.01% 3456
2021
Q3 		$212K Buy
+9,876
New +$232K ﹤0.01% 3538

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deutsche Bank's CTKB Position: Q1 2026 in Review

Deutsche Bank increased its Cytek Biosciences (CTKB) stake by 12% in Q1 2026, buying an estimated $53.3K and bringing the position to 104,437 shares worth $456K. The position accounts for ﹤0.01% of the portfolio, ranked #2617.

Deutsche Bank first reported a position in CTKB in Q3 2021 and has held it in 19 quarters since. The position peaked at $761K in Q3 2022. 165 funds tracked by Wall St. Rank hold CTKB as of Q1 2026.

  • Deutsche Bank held 104,437 shares of Cytek Biosciences worth $456K as of Q1 2026.
  • Deutsche Bank bought 11,298 Cytek Biosciences shares in Q1 2026, an estimated $53.3K.
  • Cytek Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2617 holding.
  • Deutsche Bank first reported a position in Cytek Biosciences in Q3 2021 and has held it in 19 quarters since.
  • Deutsche Bank's Cytek Biosciences position peaked at $761K in Q3 2022.
  • 165 funds tracked by Wall St. Rank held Cytek Biosciences as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.